Baudax Bio, Inc.

OTCPK:BXRX.Q Stok Raporu

Piyasa değeri: US$5.2k

Baudax Bio Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Gerri Henwood

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi5yrs
CEO sahipliği0.004%
Yönetim ortalama görev süresi1.1yrs
Yönetim Kurulu ortalama görev süresi5yrs

Son yönetim güncellemeleri

Have Insiders Been Buying Baudax Bio, Inc. (NASDAQ:BXRX) Shares?

Feb 17
Have Insiders Been Buying Baudax Bio, Inc. (NASDAQ:BXRX) Shares?

Recent updates

Baudax Bio stock down after pricing $6.2M equity offering

Aug 30

Baudax Bio to get US patent linked to pain drug Anjeso

Aug 22

Baudax Bio GAAP EPS of -$1.05 beats by $0.22, revenue of $0.3M

Aug 11

Cosette Pharmaceuticals appoints Rick Casten as CFO

Jul 06

Baudax Bio: Looking For A Turnaround In Strong COVID-19 Headwinds

Sep 09

A First Look At Baudax Bio

May 30

Baudax Bio EPS misses by $0.08, misses on revenue

May 05

Baudax Bio's Anjeso shows efficacy in pain management for total knee arthroplasty

Apr 26

Have Insiders Been Buying Baudax Bio, Inc. (NASDAQ:BXRX) Shares?

Feb 17
Have Insiders Been Buying Baudax Bio, Inc. (NASDAQ:BXRX) Shares?

Baudax Bio EPS of $0.62

Nov 09

Baudax Bio: Why I'm Catching This Falling Knife

Nov 03

CEO Tazminat Analizi

Gerri Henwood'un ücretlendirmesi Baudax Bio'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$58m

Dec 31 2022US$663kUS$618k

-US$59m

Sep 30 2022n/an/a

US$13m

Jun 30 2022n/an/a

-US$67k

Mar 31 2022n/an/a

-US$11m

Dec 31 2021US$2mUS$618k

-US$20m

Sep 30 2021n/an/a

-US$66m

Jun 30 2021n/an/a

-US$38m

Mar 31 2021n/an/a

-US$53m

Dec 31 2020US$603kUS$309k

-US$76m

Sep 30 2020n/an/a

-US$66m

Jun 30 2020n/an/a

-US$88m

Mar 31 2020n/an/a

-US$69m

Dec 31 2019US$3mUS$46k

-US$33m

Sep 30 2019n/an/a

-US$42m

Jun 30 2019n/an/a

-US$51m

Mar 31 2019n/an/a

-US$61m

Dec 31 2018US$2mUS$599k

-US$74m

Tazminat ve Piyasa: Insufficient data to establish whether Gerri's total compensation is reasonable compared to companies of similar size in the US market.

Tazminat ve Kazançlar: Gerri's compensation has been consistent with company performance over the past year.

CEO

Gerri Henwood (72 yo)

5yrs

Görev süresi

US$663,224

Tazminat

Dr. Geraldine A. Henwood, also known as Gerri, Ph D., has been the President, Chief Executive Officer and Director of Baudax Bio Inc. since 2019. She has been the Chief Development Officer of Iomab-B at Ac...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Geraldine Henwood
President5yrsUS$663.22k0.0037%
$ 0.2
Mike Choi
Vice President of Financial Planning & Analysisless than a yearVeri yokVeri yok
Natalie McAndrew
Consultant & Principle Accounting Officerless than a yearVeri yokVeri yok
Chan Kim Yong
Chief Scientific Officer & Director1.3yrsVeri yokVeri yok

1.1yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: BXRX.Q's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Geraldine Henwood
President5yrsUS$663.22k0.0037%
$ 0.2
Chan Kim Yong
Chief Scientific Officer & Director1.3yrsVeri yokVeri yok
Winston Churchill
Independent Director5yrsUS$95.11k0.0022%
$ 0.1
Wayne Weisman
Independent Chairman5.8yrsUS$113.59k0.0020%
$ 0.1
Andrew Drechsler
Independent Director4.3yrsUS$89.97k0.0020%
$ 0.1
William Ashton
Independent Director5.8yrsUS$99.97k0.0020%
$ 0.1
Arnold Baskies
Independent Director4.3yrsUS$82.47k0.0020%
$ 0.1

5.0yrs

Ortalama Görev Süresi

72yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BXRX.Q's board of directors are considered experienced (5 years average tenure).